Negative regulators of STAT3 signaling pathway in cancers. [PDF]
Wu M +7 more
europepmc +1 more source
The Dual-Edged Sword: Risks and Benefits of JAK Inhibitors in Infections. [PDF]
Jarneborn A, Kopparapu PK, Jin T.
europepmc +1 more source
JAK-STAT Signaling in Autoimmunity and Cancer. [PDF]
Parveen S +4 more
europepmc +1 more source
JAK/STAT in human diseases: a common axis in immunodeficiencies and hematological disorders. [PDF]
Djidjik R +6 more
europepmc +1 more source
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid. [PDF]
Lin X, Li X, Zhai Z, Zhang M.
europepmc +1 more source
Synthetic inhibition of the SUMO pathway by targeting the SAE1 component via TAK-981 compound impairs growth and chemosensitizes embryonal and alveolar rhabdomyosarcoma cell lines. [PDF]
Codenotti S +5 more
europepmc +1 more source
Tissue adaptation to metabolic stress: insights from SUMOylation. [PDF]
Xie H +8 more
europepmc +1 more source
The extent of coverage of health services in Brazil: PIASS - Analysis of an experience
Rosas, Eric Jenner
core
Stimuli-responsive anisotropic slippery surfaces (ASSs) have demonstrated intriguing performance in manipulating the behaviors of some liquids. However, most present methods have been limited to conductive droplets, certain specific conductive platforms ...
Chao Chen +9 more
semanticscholar +21 more sources
Related searches:
Basic Science for the Clinician 41
JCR: Journal of Clinical Rheumatology, 2006We now have an emerging sense of the details of how cytokines deliver their signals through the specific receptors to which they bind and the means by which these messages are modulated. Using common mechanisms, many of which have been described in past articles in this series, tight controls are maintained over this signaling.
L. Sigal
openaire +3 more sources

